Doctor profile · Federal record

Dr. Kathy Karamlou, MD

Rheumatology Physician (CMS: Rheumatology) · Newport Beach, CA

  • NPI 1740209303
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 28 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
361 Hospital RD Ste 428
Newport Beach, CA 926633525
(949) 631-6500
fax (949) 631-9700
Mailing address
Po Box 5688
Irvine, CA 926165688

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
March 23, 2021
Year of graduation
1998 — 28 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
California #A72397

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1740209303. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
92,858
Distinct HCPCS
10
Medicare allowed
$1,285,070
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 59,120 20 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 22,650 30 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 6,150 13 $42
J0897 Injection, denosumab, 1 mg 2,400 24 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 1,398 599 $138
99213 Established patient office or other outpatient visit, 20-29 minutes 377 327 $99
96413 Administration of chemotherapy into vein, 1 hour or less 360 64 $151
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 186 31 $84
96372 Injection of drug or substance under skin or into muscle 106 38 $16
99204 New patient office or other outpatient visit, 45-59 minutes 97 97 $180

In context: peer comparison

Among 4 peers in this city , average services per provider: 3,139. This provider delivers 30× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,484
Transactions
87
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Kyowa Kirin, Inc. 6 $1,929.83
Janssen Biotech, Inc. 12 $488.65
ABBVIE INC. 16 $278.59
Novartis Pharmaceuticals Corporation 8 $250.84
Lilly USA, LLC 17 $246.65
Mallinckrodt Hospital Products Inc. 5 $172.67
UCB, Inc. 4 $168.56
Janssen Scientific Affairs, LLC 1 $150.00
GENZYME CORPORATION 1 $137.35
SOBI, INC 2 $126.81
Alexion Pharmaceuticals, Inc. 4 $102.55
GlaxoSmithKline, LLC. 2 $91.11
PFIZER INC. 4 $85.19
Radius Health, Inc. 3 $54.54
Boehringer Ingelheim Pharmaceuticals, Inc. 2 $50.65

By nature of payment

Food and Beverage
$2,540
Consulting Fee
$1,725
Education
$174
Travel and Lodging
$45

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,421
Patients
381
Total drug cost
$46,667
Drug Type Claims Patients Total cost
Prednisone Generic 343 64 $4,286
Methotrexate (Methotrexate Sodium) Brand 211 51 $8,302
Hydroxychloroquine Sulfate Generic 163 41 $11,324
Allopurinol Generic 78 20 $806
Tramadol Hcl Generic 78 23 $702
Methylprednisolone Generic 73 51 $1,426
Sulfasalazine Dr (Sulfasalazine) Brand 71 18 $4,896
Duloxetine Hcl Generic 64 23 $2,243
Folic Acid Generic 59 15 $165
Gabapentin Generic 57 22 $669

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Kathy Karamlou's medical specialty?
Dr. Kathy Karamlou practices Rheumatology Physician in Newport Beach, CA.
Where does Dr. Kathy Karamlou practice?
Dr. Kathy Karamlou practices at 361 Hospital RD Ste 428, Newport Beach, CA 926633525. Office phone: 9496316500.
What is Dr. Kathy Karamlou's NPI?
Dr. Kathy Karamlou's National Provider Identifier (NPI) is 1740209303, issued by NPPES.
Does Dr. Kathy Karamlou accept Medicare assignment?
Yes. Dr. Kathy Karamlou accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kathy Karamlou commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.